Company Profiles

driven by the PitchBook Platform

Resolve Therapeutics

Description

Developer of biologic compounds for the treatment of autoimmune diseases. The company develops biologic drugs for the treatment of lupus that inhibits a key upstream step in the interferon cascade.

2010

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$5.8M

Latest Deal Amount

$8.88M

Total Amount Raised

Description

Developer of biologic compounds for the treatment of autoimmune diseases. The company develops biologic drugs for the treatment of lupus that inhibits a key upstream step in the interferon cascade.

Website:

www.resolvebio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery
Biotechnology

Primary Office

454 North 34th Street Seattle, WA 98103United States +1 (208) 727-7010
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Resolve Therapeutics's full profile, request a free trial.

Resolve Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Resolve Therapeutics Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Easton Capital Investment GroupVenture CapitalMinority000 0000000 0000
New Science VenturesVenture CapitalMinority000 0000000 0000
WRF CapitalVenture CapitalMinority000 0000000 0000
Easton Capital Investment Group Venture Capital
New Science Ventures Venture Capital
WRF Capital Venture Capital

Resolve Therapeutics Executive Team (2)

NameTitleBoard
Seat
Contact
Info
James Posada Ph.DFounder & Chief Executive Officer
Raj Dua Ph.DExecutive
James Posada Ph.D Founder & Chief Executive Officer
Raj Dua Ph.D Executive

Resolve Therapeutics Board Members (4)

NameRepresentingRoleSinceContact
Info
John Friedman JDEaston Capital Investment GroupFounding Partner & Managing Partner000 0000
Lisa RhoadsEaston Capital Investment GroupManaging Director000 0000
Peter Kiener Ph.DSelfChairman000 0000
Somu SubramaniamNew Science VenturesCo-Founder & Managing Partner000 0000
John Friedman JD Founding Partner & Managing Partner Easton Capital Investment Group
Lisa Rhoads Managing Director Easton Capital Investment Group
Peter Kiener Ph.D Chairman Self
Somu Subramaniam Co-Founder & Managing Partner New Science Ventures
Request full access to PitchBook